# Opko Health Inc. (OPK)

> Opko Health Inc. (OPK) trades at $1.62 (+0.00%) as of 7:44:58 PM EST on Nov 17, 2026, +0.62% over the past month. Market cap is $1.2B, with 9.2 days to cover in short interest.

Canonical: https://massive.com/quote/opk
Data as of: 2026-11-18T00:44:58.980Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$1.62** +0.00 (+0.00%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$1.60** -0.02 (-1.23%)
As of 7:44:58 PM EST on Nov 17, 2026 · After hours

## Stock performance

How Opko Health Inc. (OPK) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +0.00% |
| 1W | -5.26% |
| 1M | +0.62% |
| YTD | +28.57% |
| 1Y | +26.56% |
| 52-wk range | $0.98 – $1.86 |

From daily closes through Nov 17, 2026.

## Key statistics

Today's trading snapshot for OPK: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $1.59 – $1.65 |
| Open | $1.60 |
| Prev close | $1.62 |
| Volume | 3.03M |
| Market cap | $1.2B |
| Shares out | 742.51M |

## Valuation and profitability ratios

Valuation and profitability ratios for Opko Health Inc.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 2.40 |
| P/B | 1.08 |
| P/FCF | — |
| ROE | -13.3% |
| ROA | -7.9% |
| Debt/Equity | 0.43 |
| Div yield | 0.00% |

As of Nov 16, 2026

## Insider trading

[Opko Health Inc. (OPK) insider trading](https://massive.com/quote/opk/insider-trading.md): open-market Form 4 buys and sells by Opko Health Inc. insiders over the last 12 months.

## 8-K filings

Material corporate events Opko Health Inc. has disclosed to the SEC on Form 8-K.

- Nov 4, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 4, 2026, OPKO Health, Inc. (the "Company") issued a press release announcing operating and financial highlights for the quarter ended September 30, 2026.”
- Oct 15, 2026 · Divestiture agreement
  “On October 14, 2026, OPKO Health, Inc., its wholly owned subsidiary, BioReference Health, LLC, and Laboratory Corporation of America Holdings entered into an Asset Purchase Agreement. Pursuant to the Purchase Agreement, Seller has agreed to sell and assign to Buyer certain assets of BioReference's clinical and anatomic pathology laboratory testing business, together with certain liabilities related to the Business.”
- Aug 14, 2026 · Guarantee or letter of credit
  “its wholly-owned subsidiaries OPKO Biologics Ltd. ("OBL") and EirGen Pharma Limited ("EirGen") as guarantors (OBL and EirGen collectively, the "Guarantors")... The Guarantors have guaranteed the obligations under the Notes and have granted a security interest in certain assets of the Guarantors.”
- Mar 19, 2026 · Director appointment
  “On March 18, 2026, the Board of Directors of OPKO Health, Inc. (the "Company"), appointed Subbarao V. Uppaluri, Ph.D. as a new director with immediate effect to serve until the Company's 2026 Annual Meeting of Stockholders and until his successor shall be duly elected or appointed or his earlier death or resignation. Dr. Uppaluri is expected to be appointed to the Compensation Committee of the Board. The Board has determined that Dr. Uppaluri is independent under the applicable rules of the Securities and Exchange Commission and the Nasdaq Stock Market.”
- Sep 15, 2025 · Divestiture agreement
  “On March 10, 2025, OPKO, its wholly owned subsidiary, BioReference Health, LLC ('BioReference' and, together with OPKO, 'Seller'), and Laboratory Corporation of America Holdings, a Delaware corporation ('Buyer'), entered into an Asset Purchase Agreement (the 'Purchase Agreement'), pursuant to which Seller agreed to sell and assign to Buyer certain assets and liabilities of BioReference's laboratory testing businesses focused on oncology and oncology-related clinical testing services across the United States, in exchange for an aggregate purchase price of up to $225,000,000 in cash.”

## Similar companies

Public companies in a similar business to Opko Health Inc..

- [GMED](https://massive.com/quote/gmed.md) GLOBUS MEDICAL INC (-0.72%)
- [MMSI](https://massive.com/quote/mmsi.md) Merit Medical Systems Inc (-2.15%)

Daily change in the latest session, 15-minute delayed.

## OPK short interest

How heavily OPK is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 9.2 |
| Short interest | 32.85M |
| Avg volume | 3.56M |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## OPK news

The latest news and headlines about Opko Health Inc. (OPK).

- [Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results](https://www.globenewswire.com/news-release/2026/11/15/3403093/0/en/cocrystal-pharma-provides-business-update-and-reports-third-quarter-2026-financial-results.html) · GlobeNewswire Inc. · Nov 15, 2026 · positive sentiment
- [Hims & Hers Q3 Earnings Miss Estimates, Gross Margin Down](https://www.zacks.com/stock/news/3027910/hims-hers-q3-earnings-miss-estimates-gross-margin-down?cid=CS-ZC-FT-analyst_blog|earnings_article-3027910) · Zacks Investment Research · Nov 11, 2026 · negative sentiment
- [Rigetti Q3 Earnings In Line With Estimates, Revenues Down Y/Y](https://www.zacks.com/stock/news/3027899/rigetti-q3-earnings-in-line-with-estimates-revenues-down-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-3027899) · Zacks Investment Research · Nov 11, 2026 · negative sentiment
- [Reasons to Hold Veeva Systems Stock in Your Portfolio for Now](https://www.zacks.com/stock/news/3027481/reasons-to-hold-veeva-systems-stock-in-your-portfolio-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-3027481) · Zacks Investment Research · Nov 10, 2026 · neutral sentiment
- [BDX Stock Down in Pre-Market Despite Q4 Earnings & Revenue Beat](https://www.zacks.com/stock/news/3024701/bdx-stock-down-in-pre-market-despite-q4-earnings-revenue-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-3024701) · Zacks Investment Research · Nov 5, 2026 · neutral sentiment

## About Opko Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2.28K |
| Listed | Nov 2, 1995 |

[Company website](https://www.opko.com)

## FAQ

### What is the Opko Health Inc. (OPK) stock price today?

Opko Health Inc. (OPK) is trading at $1.62 (+0.00% on the day) as of 7:44:58 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Opko Health Inc.?

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics.

### What is the short interest in OPK?

As of Oct 30, 2026, OPK has 32.85M shares short and 9.2 days to cover.

### What exchange is OPK listed on?

Opko Health Inc. (OPK) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time OPK quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=OPK`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Opko Health Inc. (OPK) insider trading](https://massive.com/quote/opk/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
